Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc > webcast

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Feb 12, 2022 10:17pm

142 Views

Post# 34423866

RE:RE:RE:webcast

Valens finally right-sizing the co. with layoffs and cost-cutting. Co. forecasts ebitda positive by end of 2022. Not impressed. Mgmt should have their salaries cut.

lscfa wrote: The whole damn industry is avoiding giving any guidance. No visibility in an industry shake out.

jermiah777 wrote: I find that discouraging since the impression left over a year ago was that Willow is transitioning to a revenue generating company. Here we are and nothing stated about revenue? How much longer can the cash hold out? Will we need to raise more money?